Citidaron 1.5 mg tablets
*Company:
Consilient Health LtdStatus:
UpdatedLegal Category:
Product subject to medical prescription which may be renewed (B)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 17 November 2025
File name
Citidaron_SmPC.pdf
Reasons for updating
- Change to section 2 - Qualitative and quantitative composition
- Change to section 4.6 - Pregnancy and lactation
- Change to Section 4.8 – Undesirable effects - how to report a side effect
- Change to section 5.1 - Pharmacodynamic properties
- Change to section 5.2 - Pharmacokinetic properties
- Change to section 5.3 - Preclinical safety data
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
SmPC is updated due to change in INN from cytisine to cytisinicline
Updated on 17 November 2025
File name
Citidaron_PIL.pdf
Reasons for updating
- Change to section 2 - what you need to know - contraindications
- Change to section 6 - what the product contains
Free text change information supplied by the pharmaceutical company
The PIL has been updated for INN change from cytisine to cytisinicline
Updated on 14 March 2024
File name
ie-spc-clean.pdf
Reasons for updating
- Change to section 6.5 - Nature and contents of container
Legal category:Product subject to medical prescription which may be renewed (B)
Updated on 14 March 2024
File name
ie-pl-clean.pdf
Reasons for updating
- Change to section 6 - what the product looks like and pack contents
Updated on 22 January 2024
File name
2022-08-09-IE-SmPC-clean.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may be renewed (B)
Free text change information supplied by the pharmaceutical company
New SPC
Updated on 22 January 2024
File name
2023-10-25_ie-pl-clean.pdf
Reasons for updating
- New PIL for new product
Consilient Health Ltd
Address:
Block 2A Richview Office Park, Clonskeagh, Dublin 14, IrelandMedical Information E-mail:
drugsafety@consilienthealth.comTelephone:
353 1 2057760Medical Information Facsimile:
+44 (0) 203 751 1889Medical Information Direct Line:
+44 (0) 203 751 1888